Two peer-reviewed studies examine cryoablation's role in breast cancer care
Go back to Two peer-reviewed studies examine cryoablation's role in breast cancer care| (NASDAQ: ICCM) | Delayed: 2.19 -0.04 (1.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.23 | 52 Week High | $ | |||
| Open | $2.25 | 52 Week Low | $ | |||
| Day High | $2.25 | P/E | N/A | |||
| Day Low | $2.17 | EPS | $ | |||
| Volume | 41,597 | |||||
